HL7 Europe Base and Core FHIR IG
2.0.0 - trial-use 150

HL7 Europe Base and Core FHIR IG, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/base/ and changes regularly. See the Directory of published versions

## ValueSet: Medical Test Result Code

Official URL: http://hl7.eu/fhir/base/ValueSet/medicalTestResult-eu | Version: 2.0.0
Active as of 2026-08-31 | Computable Name: MedicalTestResultCodeEuVs
Copyright/Legal: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc

Medical test result codes. List of Medical test result codes containing LOINC and NPU.

References

- Observation: Medical Test Result (EU core)

### Logical Definition (CLD)

This value set includes codes based on the following rules:

- Include all codes defined in `http://loinc.org` version Not Stated (use latest from terminology server)
- Include codes from`http://snomed.info/sct` version Not Stated (use latest from terminology server) where concept is-a 363787002 (Observable entity)

### Expansion

Expansion from tx.fhir.org based on:

- Loinc v2.82
- SNOMED CT International edition 01-Feb 2025

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

System | Code | Display (en) | status | JSON | XML
`http://loinc.org` | 100000-9 | Health informatics pioneer and the father of LOINC |  |  |
`http://loinc.org` | 100001-7 | Health informatics pioneer and cofounder of LOINC |  |  |
`http://loinc.org` | 100002-5 | Specimen care is maintained |  |  |
`http://loinc.org` | 100003-3 | Team communication is maintained throughout care |  |  |
`http://loinc.org` | 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure |  |  |
`http://loinc.org` | 100005-8 | Demonstrates knowledge of nutritional management related to the procedure |  |  |
`http://loinc.org` | 100006-6 | Demonstrates knowledge of medication management |  |  |
`http://loinc.org` | 100007-4 | Demonstrates knowledge of pain management |  |  |
`http://loinc.org` | 10000-8 | R wave duration in lead AVR |  |  |
`http://loinc.org` | 100008-2 | Demonstrates knowledge of wound management |  |  |
`http://loinc.org` | 100009-0 | Demonstrates knowledge of the procedure and expected results |  |  |
`http://loinc.org` | 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation |  |  |
`http://loinc.org` | 100011-6 | No injury related to an electrical source |  |  |
`http://loinc.org` | 100012-4 | Participates in decisions affecting the patient's plan of care |  |  |
`http://loinc.org` | 100013-2 | Participates in the discharge process |  |  |
`http://loinc.org` | 100014-0 | Psychosocial health is maintained at or improved from baseline |  |  |
`http://loinc.org` | 100015-7 | No injury related to positioning due to care or procedure |  |  |
`http://loinc.org` | 10001-6 | R wave duration in lead I |  |  |
`http://loinc.org` | 100016-5 | No injury related to a laser source |  |  |
`http://loinc.org` | 100017-3 | Perioperative nursing data set outcomes panel [PNDS] |  |  |
`http://loinc.org` | 100018-1 | Hospice care Note |  |  |
`http://loinc.org` | 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 10002-4 | R wave duration in lead II |  |  |
`http://loinc.org` | 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |  |  |
`http://loinc.org` | 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 10003-2 | R wave duration in lead III |  |  |
`http://loinc.org` | 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 100034-8 | Provider of automated external defibrillator use |  |  |
`http://loinc.org` | 100035-5 | Exam finding location of Chest |  |  |
`http://loinc.org` | 100036-3 | Exam finding location of Lung |  |  |
`http://loinc.org` | 100037-1 | Patient contact disposition EMS unit |  |  |
`http://loinc.org` | 100038-9 | Patient evaluation disposition EMS unit |  |  |
`http://loinc.org` | 100039-7 | Crew disposition for patient care EMS unit |  |  |
`http://loinc.org` | 10004-0 | R wave duration in lead V1 |  |  |
`http://loinc.org` | 100040-5 | Patient transport disposition EMS unit |  |  |
`http://loinc.org` | 100041-3 | Aminoglycoside [Susceptibility] |  |  |
`http://loinc.org` | 100042-1 | Atovaquone [Susceptibility] |  |  |
`http://loinc.org` | 100043-9 | Azithromycin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100044-7 | Cefcapene [Susceptibility] |  |  |
`http://loinc.org` | 100045-4 | Cefozopran [Susceptibility] |  |  |
`http://loinc.org` | 100046-2 | Cefquinome [Susceptibility] |  |  |
`http://loinc.org` | 100047-0 | Cefteram [Susceptibility] |  |  |
`http://loinc.org` | 100048-8 | Clarithromycin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100049-6 | Eravacycline [Susceptibility] |  |  |
`http://loinc.org` | 100050-4 | Erythromycin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100051-2 | Ethambutol+rifAMPin [Susceptibility] |  |  |
`http://loinc.org` | 100052-0 | Flomoxef [Susceptibility] |  |  |
`http://loinc.org` | 100053-8 | Fluoroquinolone [Susceptibility] |  |  |
`http://loinc.org` | 100054-6 | Gamithromycin [Susceptibility] |  |  |
`http://loinc.org` | 100055-3 | Optochin [Susceptibility] |  |  |
`http://loinc.org` | 100056-1 | Panipenem [Susceptibility] |  |  |
`http://loinc.org` | 10005-7 | R wave duration in lead V2 |  |  |
`http://loinc.org` | 100057-9 | Prothionamide [Susceptibility] |  |  |
`http://loinc.org` | 100058-7 | Prulifloxacin [Susceptibility] |  |  |
`http://loinc.org` | 100059-5 | Rifapentine [Susceptibility] |  |  |
`http://loinc.org` | 100060-3 | Tildipirosin [Susceptibility] |  |  |
`http://loinc.org` | 100061-1 | Tosufloxacin [Susceptibility] |  |  |
`http://loinc.org` | 100062-9 | Standard Dermatology Outcome Measures panel |  |  |
`http://loinc.org` | 100063-7 | Primary skin concern |  |  |
`http://loinc.org` | 100064-5 | Itch severity Reporting Period - Reported |  |  |
`http://loinc.org` | 10006-5 | R wave duration in lead V3 |  |  |
`http://loinc.org` | 100065-2 | Satisfied with treatment |  |  |
`http://loinc.org` | 100066-0 | Specular microscopy panel | TRIAL |  |
`http://loinc.org` | 100067-8 | Eye Image magnification | TRIAL |  |
`http://loinc.org` | 100068-6 | Right eye Fixation point [Angle] | TRIAL |  |
`http://loinc.org` | 100069-4 | Left eye Fixation point [Angle] | TRIAL |  |
`http://loinc.org` | 100070-2 | Right cornea Cell density | TRIAL |  |
`http://loinc.org` | 100071-0 | Left cornea Cell density | TRIAL |  |
`http://loinc.org` | 100072-8 | Right cornea Coefficient of variation | TRIAL |  |
`http://loinc.org` | 10007-3 | R wave duration in lead V4 |  |  |
`http://loinc.org` | 100073-6 | Left cornea Coefficient of variation | TRIAL |  |
`http://loinc.org` | 100074-4 | Right cornea Hexagonality | TRIAL |  |
`http://loinc.org` | 100075-1 | Left cornea Hexagonality | TRIAL |  |
`http://loinc.org` | 100076-9 | Right cornea Endothelial cells counted | TRIAL |  |
`http://loinc.org` | 100077-7 | Left cornea Endothelial cells counted | TRIAL |  |
`http://loinc.org` | 100078-5 | Right cornea Endothelial cell area.min | TRIAL |  |
`http://loinc.org` | 100079-3 | Left cornea Endothelial cell area.min | TRIAL |  |
`http://loinc.org` | 100080-1 | Right cornea Endothelial cell area.max | TRIAL |  |
`http://loinc.org` | 10008-1 | R wave duration in lead V5 |  |  |
`http://loinc.org` | 100081-9 | Left cornea Endothelial cell area.max | TRIAL |  |
`http://loinc.org` | 100082-7 | Right cornea Endothelial cell area.mean | TRIAL |  |
`http://loinc.org` | 100083-5 | Left cornea Endothelial cell area.mean | TRIAL |  |
`http://loinc.org` | 100084-3 | Right cornea Cell area.standard deviation | TRIAL |  |
`http://loinc.org` | 100085-0 | Left cornea Cell area.standard deviation | TRIAL |  |
`http://loinc.org` | 100086-8 | Right cornea Type of Analysis method by Specular microscopy | TRIAL |  |
`http://loinc.org` | 100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |  |  |
`http://loinc.org` | 100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 10009-9 | R wave duration in lead V6 |  |  |
`http://loinc.org` | 100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100105-6 | Filaria IgG and IgM panel - Serum |  |  |
`http://loinc.org` | 100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 10010-7 | R' wave amplitude in lead AVF |  |  |
`http://loinc.org` | 100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100113-0 | Helicobacter pylori Ab panel - Serum |  |  |
`http://loinc.org` | 100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 10011-5 | R' wave amplitude in lead AVL |  |  |
`http://loinc.org` | 100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100120-5 | Chlamydia trachomatis Ab panel - Serum |  |  |
`http://loinc.org` | 100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100122-1 | Chlamydophila pneumoniae Ab panel - Serum |  |  |
`http://loinc.org` | 10012-3 | R' wave amplitude in lead AVR |  |  |
`http://loinc.org` | 100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100125-4 | Chlamydophila psittaci Ab panel - Serum |  |  |
`http://loinc.org` | 100126-2 | Bordetella pertussis Ab.IgG panel - Serum |  |  |
`http://loinc.org` | 100127-0 | Campylobacter sp Ab panel - Serum |  |  |
`http://loinc.org` | 100128-8 | Cryptococcus sp Ag panel - Serum |  |  |
`http://loinc.org` | 100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |  |  |
`http://loinc.org` | 100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 10013-1 | R' wave amplitude in lead I |  |  |
`http://loinc.org` | 100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 10014-9 | R' wave amplitude in lead II |  |  |
`http://loinc.org` | 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |  |  |
`http://loinc.org` | 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |  |  |
`http://loinc.org` | 100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |  |  |
`http://loinc.org` | 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |  |  |
`http://loinc.org` | 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |  |  |
`http://loinc.org` | 100154-4 | Specimen collection supervision level |  |  |
`http://loinc.org` | 100155-1 | Left cornea Type of Analysis method by Specular microscopy | TRIAL |  |
`http://loinc.org` | 10015-6 | R' wave amplitude in lead III |  |  |
`http://loinc.org` | 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |  |  |
`http://loinc.org` | 100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration |  |  |
`http://loinc.org` | 100159-3 | Knee Society Score pre-op panel [Knee Society Score] |  |  |
`http://loinc.org` | 100160-1 | Knee replacement |  |  |
`http://loinc.org` | 100161-9 | Charnley Functional Classification |  |  |
`http://loinc.org` | 100162-7 | Knee alignment W standing X-ray measured |  |  |
`http://loinc.org` | 100163-5 | Knee medial AndOr lateral instability W full extension |  |  |
`http://loinc.org` | 10016-4 | R' wave amplitude in lead V1 |  |  |
`http://loinc.org` | 100164-3 | Knee AP instability W 90 degree flexion |  |  |
`http://loinc.org` | 100165-0 | Knee range of motion |  |  |
`http://loinc.org` | 100166-8 | Flexion contracture range of Knee |  |  |
`http://loinc.org` | 100167-6 | Extensor lag range of Knee |  |  |
`http://loinc.org` | 100168-4 | Knee pain severity with level walking |  |  |
`http://loinc.org` | 100169-2 | Knee pain severity with stairs or inclines |  |  |
`http://loinc.org` | 1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor |  |  |
`http://loinc.org` | 100170-0 | Knee feels normal |  |  |
`http://loinc.org` | 100171-8 | Satisfaction with level of knee pain while sitting |  |  |
`http://loinc.org` | 10017-2 | R' wave amplitude in lead V2 |  |  |
`http://loinc.org` | 100172-6 | Satisfaction with level of knee pain while lying in bed |  |  |
`http://loinc.org` | 100173-4 | Satisfaction with knee function while getting out of bed |  |  |
`http://loinc.org` | 100174-2 | Satisfaction with knee function while performing light household duties |  |  |
`http://loinc.org` | 100175-9 | Satisfaction with knee function while performing recreational activities |  |  |
`http://loinc.org` | 100176-7 | Expect surgery to relieve pain |  |  |
`http://loinc.org` | 100177-5 | Expect surgery will improve ability to perform activities of daily living |  |  |
`http://loinc.org` | 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities |  |  |
`http://loinc.org` | 100179-1 | Walk without assistive mobility devices |  |  |
`http://loinc.org` | 10018-0 | R' wave amplitude in lead V3 |  |  |
`http://loinc.org` | 100180-9 | Assistive mobility devices used |  |  |
`http://loinc.org` | 100181-7 | Assistive mobility devices used due to health condition |  |  |
`http://loinc.org` | 100182-5 | Duration of standing before sitting due to knee discomfort |  |  |
`http://loinc.org` | 100183-3 | Duration of walking before stopping due to knee discomfort |  |  |
`http://loinc.org` | 100184-1 | How bothersome is knee when walking on an uneven surface |  |  |
`http://loinc.org` | 100185-8 | How bothersome is knee when turning or pivoting leg |  |  |
`http://loinc.org` | 100186-6 | How bothersome is knee when climbing up or down a flight of stairs |  |  |
`http://loinc.org` | 100187-4 | How bothersome is knee when getting up from a low seat without armrests |  |  |
`http://loinc.org` | 100188-2 | How bothersome is knee when getting into or out of a car |  |  |
`http://loinc.org` | 100189-0 | How bothersome is knee when moving laterally |  |  |
`http://loinc.org` | 100190-8 | How bothersome is knee when climbing a ladder or step stool |  |  |
`http://loinc.org` | 100191-6 | How bothersome is knee when carrying a bag for one block |  |  |
`http://loinc.org` | 100192-4 | How bothersome is knee when squatting |  |  |
`http://loinc.org` | 100193-2 | How bothersome is knee when kneeling |  |  |
`http://loinc.org` | 100194-0 | How bothersome is knee when running |  |  |
`http://loinc.org` | 100195-7 | Pain severity--during activity |  |  |
`http://loinc.org` | 100196-5 | Pre-op total score [Knee Society Score] |  |  |
`http://loinc.org` | 100197-3 | Exercise activity and pain severity panel |  |  |
`http://loinc.org` | 10019-8 | R' wave amplitude in lead V4 |  |  |
`http://loinc.org` | 100198-1 | Pre-op objective knee indicators score [Knee Society Score] |  |  |
`http://loinc.org` | 100199-9 | Pre-op symptoms score [Knee Society Score] |  |  |
`http://loinc.org` | 100200-5 | Pre-op patient expectations score [Knee Society Score] |  |  |
`http://loinc.org` | 100201-3 | Pre-op functional activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100203-9 | Knee Society Score post-op panel [Knee Society Score] |  |  |
`http://loinc.org` | 100204-7 | Accuracy of pre-surgery expectations of pain relief |  |  |
`http://loinc.org` | 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living |  |  |
`http://loinc.org` | 10020-6 | R' wave amplitude in lead V5 |  |  |
`http://loinc.org` | 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |  |  |
`http://loinc.org` | 100207-0 | Post-op total score [Knee Society Score] |  |  |
`http://loinc.org` | 100208-8 | Post-op objective knee indicators score [Knee Society Score] |  |  |
`http://loinc.org` | 100209-6 | Post-op symptoms score [Knee Society Score] |  |  |
`http://loinc.org` | 100210-4 | Post-op patient expectations score [Knee Society Score] |  |  |
`http://loinc.org` | 100211-2 | Post-op functional activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100212-0 | Post-op discretionary knee activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 10021-4 | R' wave amplitude in lead V6 |  |  |
`http://loinc.org` | 100214-6 | Dental model prior authorization Document |  |  |
`http://loinc.org` | 100215-3 | Episode of care medical records Document Transplant surgery |  |  |
`http://loinc.org` | 100216-1 | Surgical synoptic report |  |  |
`http://loinc.org` | 100217-9 | Synoptic report Document Surgical oncology |  |  |
`http://loinc.org` | 100218-7 | Surgical oncology of colon cancer synoptic report |  |  |
`http://loinc.org` | 100219-5 | Surgical oncology of melanoma cancer synoptic report |  |  |
`http://loinc.org` | 100220-3 | Surgical oncology of breast cancer synoptic report |  |  |
`http://loinc.org` | 100221-1 | Surgical oncology of thyroid cancer synoptic report |  |  |
`http://loinc.org` | 10022-2 | R' wave duration in lead AVF |  |  |
`http://loinc.org` | 100222-9 | Surgical oncology of pancreas cancer synoptic report |  |  |
`http://loinc.org` | 100223-7 | Physical findings of Retina Narrative |  |  |
`http://loinc.org` | 100224-5 | Cardiac left ventricular segmental wall motion by echo panel |  |  |
`http://loinc.org` | 100225-2 | Bone density quantitative ultrasound study |  |  |
`http://loinc.org` | 100226-0 | Small bowel capsule endoscopy study Document |  |  |
`http://loinc.org` | 100227-8 | Colon capsule endoscopy study Document |  |  |
`http://loinc.org` | 100228-6 | Upper gastrointestinal capsule endoscopy study Document |  |  |
`http://loinc.org` | 100229-4 | Endoscopic ultrasound study Document |  |  |
`http://loinc.org` | 10023-0 | R' wave duration in lead AVL |  |  |
`http://loinc.org` | 100230-2 | Routine prenatal assessment panel |  |  |
`http://loinc.org` | 100231-0 | Endobronchial ultrasound study |  |  |
`http://loinc.org` | 100232-8 | Impacts of Events Scale-Revised panel |  |  |
`http://loinc.org` | 100233-6 | Reminders brought back feelings about adverse event |  |  |
`http://loinc.org` | 100234-4 | Trouble staying asleep |  |  |
`http://loinc.org` | 100235-1 | Other things triggered persistent thoughts about adverse event |  |  |
`http://loinc.org` | 100236-9 | Felt irritable AndOr angry |  |  |
`http://loinc.org` | 100237-7 | Avoided getting upset when unintentionally thought about adverse event |  |  |
`http://loinc.org` | 100238-5 | Thought about adverse event unintentionally |  |  |
`http://loinc.org` | 100239-3 | Felt as if adverse event did not happen |  |  |
`http://loinc.org` | 100240-1 | Avoided reminders of adverse event |  |  |
`http://loinc.org` | 100241-9 | Experienced mental images of adverse event |  |  |
`http://loinc.org` | 100242-7 | Easily startled |  |  |
`http://loinc.org` | 100243-5 | Tried to not think of adverse event |  |  |
`http://loinc.org` | 100244-3 | Aware of feelings about adverse event, but did not address them |  |  |
`http://loinc.org` | 100245-0 | Feelings about adverse event were numb |  |  |
`http://loinc.org` | 100246-8 | Acted or felt the same as during adverse event |  |  |
`http://loinc.org` | 100247-6 | Trouble falling asleep |  |  |
`http://loinc.org` | 10024-8 | R' wave duration in lead AVR |  |  |
`http://loinc.org` | 100248-4 | Waves of strong feelings about adverse event |  |  |
`http://loinc.org` | 100249-2 | Tried to remove adverse event from memory |  |  |
`http://loinc.org` | 1002-5 | DBG Ab [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100250-0 | Trouble concentrating |  |  |
`http://loinc.org` | 100251-8 | Reminders of adverse event caused physical reactions |  |  |
`http://loinc.org` | 100252-6 | Had dreams about adverse event |  |  |
`http://loinc.org` | 100253-4 | Felt watchful and on-guard |  |  |
`http://loinc.org` | 100254-2 | Tried not to talk about adverse event |  |  |
`http://loinc.org` | 10025-5 | R' wave duration in lead I |  |  |
`http://loinc.org` | 100255-9 | Total score [Impact of Event Scale-Revised] |  |  |
`http://loinc.org` | 100256-7 | Fallen in last 6 months |  |  |
`http://loinc.org` | 100257-5 | Feel unsteady when standing or walking |  |  |
`http://loinc.org` | 100258-3 | History of fall related injury |  |  |
`http://loinc.org` | 100259-1 | Aware of tactile sensations |  |  |
`http://loinc.org` | 100260-9 | Easy to describe thoughts AndOr feelings |  |  |
`http://loinc.org` | 100261-7 | Critical of own thoughts AndOr feelings |  |  |
`http://loinc.org` | 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react |  |  |
`http://loinc.org` | 10026-3 | R' wave duration in lead II |  |  |
`http://loinc.org` | 100263-3 | Easily distracted |  |  |
`http://loinc.org` | 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed |  |  |
`http://loinc.org` | 100265-8 | Aware of dietary intake impact on self |  |  |
`http://loinc.org` | 100266-6 | Difficult to describe thoughts AndOr feelings |  |  |
`http://loinc.org` | 100267-4 | Aware of auditory stimuli |  |  |
`http://loinc.org` | 100268-2 | Able to avoid immediate reaction in difficult situations |  |  |
`http://loinc.org` | 100269-0 | Do things without paying attention |  |  |
`http://loinc.org` | 100270-8 | Recover quickly from distressing thoughts AndOr images |  |  |
`http://loinc.org` | 10027-1 | R' wave duration in lead III |  |  |
`http://loinc.org` | 100271-6 | Aware of olfactory stimuli |  |  |
`http://loinc.org` | 100272-4 | Aware of visual stimuli |  |  |
`http://loinc.org` | 100273-2 | Aware of emotions affect on thoughts AndOr behavior |  |  |
`http://loinc.org` | 100274-0 | Observing score [FFMQ] |  |  |
`http://loinc.org` | 100275-7 | Describing score [FFMQ] |  |  |
`http://loinc.org` | 100276-5 | Acting with awareness score [FFMQ] |  |  |
`http://loinc.org` | 100277-3 | Nonjudging score [FFMQ] |  |  |
`http://loinc.org` | 100278-1 | Nonreactivity score [FFMQ] |  |  |
`http://loinc.org` | 100279-9 | Total score [FFMQ] |  |  |
`http://loinc.org` | 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] |  |  |
`http://loinc.org` | 100281-5 | D Ab [Units/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100282-3 | Vaccine exemption certificate |  |  |
`http://loinc.org` | 100283-1 | Harris Hip Score panel [Harris Hip Score] |  |  |
`http://loinc.org` | 100284-9 | Walking - functional ability |  |  |
`http://loinc.org` | 100285-6 | Comfortable seated position |  |  |
`http://loinc.org` | 100286-4 | Able to board public transportation |  |  |
`http://loinc.org` | 100287-2 | Put on shoes and socks |  |  |
`http://loinc.org` | 100288-0 | Absence of deformity score [Harris Hip Score] |  |  |
`http://loinc.org` | 10028-9 | R' wave duration in lead V1 |  |  |
`http://loinc.org` | 100289-8 | Absence of hip deformity measurements |  |  |
`http://loinc.org` | 100290-6 | Range of motion score [Harris Hip Score] |  |  |
`http://loinc.org` | 100291-4 | Total score [Harris Hip Score] |  |  |
`http://loinc.org` | 100292-2 | Pre-op patient satisfaction score [Knee Society Score] |  |  |
`http://loinc.org` | 100293-0 | Hip Flexion range of motion |  |  |
`http://loinc.org` | 100294-8 | Hip Abduction range of motion |  |  |
`http://loinc.org` | 100295-5 | Hip Adduction range of motion |  |  |
`http://loinc.org` | 100296-3 | Hip External rotation range of motion |  |  |
`http://loinc.org` | 10029-7 | R' wave duration in lead V2 |  |  |
`http://loinc.org` | 100297-1 | Hip Internal rotation range of motion |  |  |
`http://loinc.org` | 100298-9 | Repetition count |  |  |
`http://loinc.org` | 100299-7 | Post-op patient satisfaction score [Knee Society Score] |  |  |
`http://loinc.org` | 100300-3 | End time Unspecified body region |  |  |
`http://loinc.org` | 100301-1 | Start time Unspecified body region |  |  |
`http://loinc.org` | 100302-9 | Time period start and end panel Unspecified body region |  |  |
`http://loinc.org` | 100303-7 | Condition certainty of presence |  |  |
`http://loinc.org` | 100304-5 | Flights climbed [#] Reporting Period |  |  |
`http://loinc.org` | 10030-5 | R' wave duration in lead V3 |  |  |
`http://loinc.org` | 100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |  |  |
`http://loinc.org` | 100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |  |  |
`http://loinc.org` | 100307-8 | Behavioral screening elder mistreatment |  |  |
`http://loinc.org` | 100308-6 | Need help getting to essential places |  |  |
`http://loinc.org` | 100309-4 | Activity support person |  |  |
`http://loinc.org` | 100310-2 | Reliability of support person |  |  |
`http://loinc.org` | 100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house |  |  |
`http://loinc.org` | 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house |  |  |
`http://loinc.org` | 10031-3 | R' wave duration in lead V4 |  |  |
`http://loinc.org` | 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day |  |  |
`http://loinc.org` | 100314-4 | Need help with house cleaning or yard work |  |  |
`http://loinc.org` | 100315-1 | Need help getting out of bed, showered, or dressed |  |  |
`http://loinc.org` | 100316-9 | Need help to make sure bills get paid |  |  |
`http://loinc.org` | 100317-7 | Relationship of usual support person for daily activities |  |  |
`http://loinc.org` | 100318-5 | Have help with finances AndOr financial decisions |  |  |
`http://loinc.org` | 100319-3 | Relationship of financial support person |  |  |
`http://loinc.org` | 100320-1 | Financial support person usually asks for permission before making decisions |  |  |
`http://loinc.org` | 10032-1 | R' wave duration in lead V5 |  |  |
`http://loinc.org` | 100321-9 | Financial support person usually makes good decisions about finances |  |  |
`http://loinc.org` | 100322-7 | Have access to paperwork for financial decisions made |  |  |
`http://loinc.org` | 100323-5 | Financial support person forged signature |  |  |
`http://loinc.org` | 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions |  |  |
`http://loinc.org` | 100325-0 | Experienced theft by support person |  |  |
`http://loinc.org` | 100326-8 | Money spent or property sold without permission |  |  |
`http://loinc.org` | 100327-6 | Stranger forged signature for financial gain |  |  |
`http://loinc.org` | 100328-4 | Stranger forced document signature for financial gain |  |  |
`http://loinc.org` | 100329-2 | Feared for safety due to verbal attack |  |  |
`http://loinc.org` | 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100330-0 | Felt humiliated due to ridicule |  |  |
`http://loinc.org` | 100331-8 | Coerced to do something |  |  |
`http://loinc.org` | 100332-6 | Ignored by close friend or relative for extended period |  |  |
`http://loinc.org` | 100333-4 | Physically hit or threatened |  |  |
`http://loinc.org` | 100334-2 | Been physically hurt with some degree of injury |  |  |
`http://loinc.org` | 100335-9 | Coerced sexual activity |  |  |
`http://loinc.org` | 100336-7 | Coerced touching of private body parts of self or others |  |  |
`http://loinc.org` | 100337-5 | Coerced to undress or expose private body area |  |  |
`http://loinc.org` | 100338-3 | Photographed in any degree of nudity without consent |  |  |
`http://loinc.org` | 10033-9 | R' wave duration in lead V6 |  |  |
`http://loinc.org` | 100339-1 | Experienced attempted physical restraint |  |  |
`http://loinc.org` | 100340-9 | Range of motion panel Hip |  |  |
`http://loinc.org` | 100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |  |  |
`http://loinc.org` | 100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |  |  |
`http://loinc.org` | 100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |  |  |
`http://loinc.org` | 100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |  |  |
`http://loinc.org` | 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100346-6 | Clotting time of Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited |  |  |
`http://loinc.org` | 10034-7 | S wave amplitude in lead AVF |  |  |
`http://loinc.org` | 100347-4 | Clot formation [Time] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited |  |  |
`http://loinc.org` | 100348-2 | Model for end-stage liver disease sodium score |  |  |
`http://loinc.org` | 100349-0 | US.doppler Penis vessels W vasodilator IV |  |  |
`http://loinc.org` | 100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100351-6 | Pioglitazone [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100352-4 | Rosiglitazone [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] |  |  |
`http://loinc.org` | 10035-4 | S wave amplitude in lead AVL |  |  |
`http://loinc.org` | 100354-0 | Frequency of participating in multi-modal communication without assistance |  |  |
`http://loinc.org` | 100355-7 | Frequency of participating in spoken language expression communication without assistance |  |  |
`http://loinc.org` | 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100357-3 | Naloxone [Presence] in Cord tissue by Screen method |  |  |
`http://loinc.org` | 100358-1 | Phentermine [Presence] in Cord tissue by Screen method |  |  |
`http://loinc.org` | 100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |  |  |
`http://loinc.org` | 100360-7 | Brief Resilience Scale panel [BRS] |  |  |
`http://loinc.org` | 100361-5 | Quickly recover from bad events |  |  |
`http://loinc.org` | 10036-2 | S wave amplitude in lead AVR |  |  |
`http://loinc.org` | 100362-3 | Difficulty making it through stressful events |  |  |
`http://loinc.org` | 100363-1 | Easily recover from a stressful event |  |  |
`http://loinc.org` | 100364-9 | Difficulty recovering from bad events |  |  |
`http://loinc.org` | 100365-6 | Easily recover from difficulties |  |  |
`http://loinc.org` | 100366-4 | Lengthy recovery from setbacks |  |  |
`http://loinc.org` | 100367-2 | Total Score BRS |  |  |
`http://loinc.org` | 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |  |  |
`http://loinc.org` | 100369-8 | NM Thyroid gland Views W Tl-201 IV |  |  |
`http://loinc.org` | 10037-0 | S wave amplitude in lead I |  |  |
`http://loinc.org` | 100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100372-2 | Abiraterone [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100373-0 | Eucheuma IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100374-8 | Aloe vera IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100375-5 | Anise IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100376-3 | Bamboo sprouts IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100377-1 | Goat cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100379-7 | Leeks IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100380-5 | Red cabbage IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100381-3 | Peppermint IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100382-1 | FDA package insert REMS addressed risk |  |  |
`http://loinc.org` | 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100384-7 | Turnip IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100385-4 | Corn salad IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100386-2 | Rosemary IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10038-8 | S wave amplitude in lead II |  |  |
`http://loinc.org` | 100388-8 | Cocoa IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100389-6 | Pistachio IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100391-2 | Dates IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100392-0 | Duck meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100394-6 | Astacoidea IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100395-3 | Carob IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10039-6 | S wave amplitude in lead III |  |  |
`http://loinc.org` | 100396-1 | Rapeseed IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100397-9 | Goat Meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100398-7 | Goose meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100400-1 | Quail meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100402-7 | Venison meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100403-5 | Guineafowl IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10040-4 | S wave amplitude in lead V1 |  |  |
`http://loinc.org` | 100404-3 | Horse meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100405-0 | Kefir IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100406-8 | Butter IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100409-2 | Processed cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |  |  |
`http://loinc.org` | 100410-0 | Curd cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10041-2 | S wave amplitude in lead V2 |  |  |
`http://loinc.org` | 100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100414-2 | Gourd IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100415-9 | Kale IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100418-3 | Liquorice IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100419-1 | Snow pea IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10042-0 | S wave amplitude in lead V3 |  |  |
`http://loinc.org` | 100420-9 | Fava bean IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100421-7 | Chickpea IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100422-5 | Common Chicory IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitake + chanterelle mushroom) IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100426-6 | Squalene [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100428-2 | Carnitine free and total and acylcarnitine panel - Urine |  |  |
`http://loinc.org` | 100429-0 | LRBA deficiency panel - Blood |  |  |
`http://loinc.org` | 100430-8 | Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100432-4 | Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method |  |  |
`http://loinc.org` | 10043-8 | S wave amplitude in lead V4 |  |  |
`http://loinc.org` | 100438-1 | Adolescent medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100439-9 | Allergy and Immunology Outpatient Progress note |  |  |
`http://loinc.org` | 100440-7 | Allergy Outpatient Progress note |  |  |
`http://loinc.org` | 100441-5 | Attending Outpatient Progress note |  |  |
`http://loinc.org` | 100442-3 | Audiology Outpatient Progress note |  |  |
`http://loinc.org` | 100443-1 | Bariatric surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100444-9 | Blood banking and transfusion medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100445-6 | Bone Marrow Transplant Outpatient Progress note |  |  |
`http://loinc.org` | 10044-6 | S wave amplitude in lead V5 |  |  |
`http://loinc.org` | 100446-4 | Breastfeeding Outpatient Progress note |  |  |
`http://loinc.org` | 100447-2 | Burn management Outpatient Progress note |  |  |
`http://loinc.org` | 100448-0 | Cardiac surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100449-8 | Cardiopulmonary Outpatient Progress note |  |  |
`http://loinc.org` | 100450-6 | Child and adolescent psychiatry Outpatient Progress note |  |  |
`http://loinc.org` | 100451-4 | Chiropractic medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100452-2 | Clinical cardiac electrophysiology Outpatient Progress note |  |  |
`http://loinc.org` | 10045-3 | S wave amplitude in lead V6 |  |  |
`http://loinc.org` | 100453-0 | Clinical genetics Outpatient Progress note |  |  |
`http://loinc.org` | 100454-8 | Clinical neurophysiology Outpatient Progress note |  |  |
`http://loinc.org` | 100455-5 | Clinical pathology Outpatient Progress note |  |  |
`http://loinc.org` | 100456-3 | Colon and rectal surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100457-1 | Consultant Outpatient Progress note |  |  |
`http://loinc.org` | 100458-9 | Outpatient COVID-19 Intubation Progress note |  |  |
`http://loinc.org` | 100459-7 | Outpatient COVID-19 Progress note |  |  |
`http://loinc.org` | 100460-5 | Dermatology Outpatient Progress note |  |  |
`http://loinc.org` | 10046-1 | S wave duration in lead AVF |  |  |
`http://loinc.org` | 100461-3 | Developmental-behavioral pediatrics Outpatient Progress note |  |  |
`http://loinc.org` | 100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note |  |  |
`http://loinc.org` | 100463-9 | Eating disorders Outpatient Progress note |  |  |
`http://loinc.org` | 100464-7 | Endocrinology Outpatient Progress note |  |  |
`http://loinc.org` | 100465-4 | Family medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100466-2 | Gastroenterology Outpatient Progress note |  |  |
`http://loinc.org` | 100467-0 | Geriatric medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100468-8 | Gynecologic oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100469-6 | Gynecology Outpatient Progress note |  |  |
`http://loinc.org` | 100470-4 | Healthcare navigator Outpatient Progress note |  |  |
`http://loinc.org` | 100471-2 | Heart failure Outpatient Progress note |  |  |
`http://loinc.org` | 100472-0 | Heart failure+Transplant cardiology Outpatient Progress note |  |  |
`http://loinc.org` | 100473-8 | Hematology Outpatient Progress note |  |  |
`http://loinc.org` | 100474-6 | Hematology+Medical oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100475-3 | Hepatology Outpatient Progress note |  |  |
`http://loinc.org` | 100476-1 | Immunology Outpatient Progress note |  |  |
`http://loinc.org` | 100477-9 | Infectious disease Outpatient Progress note |  |  |
`http://loinc.org` | 100478-7 | Internal medicine Outpatient Progress note |  |  |
`http://loinc.org` | 10047-9 | S wave duration in lead AVL |  |  |
`http://loinc.org` | 100479-5 | Interventional cardiology Outpatient Progress note |  |  |
`http://loinc.org` | 100480-3 | Interventional radiology Outpatient Progress note |  |  |
`http://loinc.org` | 100481-1 | Outpatient Mechanical circulatory support Progress note |  |  |
`http://loinc.org` | 100482-9 | Medical Aid in Dying Outpatient Progress note |  |  |
`http://loinc.org` | 100483-7 | Mental health Outpatient Progress note |  |  |
`http://loinc.org` | 100484-5 | Multi-specialty program Outpatient Progress note |  |  |
`http://loinc.org` | 100485-2 | Neonatal perinatal medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100486-0 | Nephrology Outpatient Progress note |  |  |
`http://loinc.org` | 10048-7 | S wave duration in lead AVR |  |  |
`http://loinc.org` | 100487-8 | Neurological surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100488-6 | Neurology Outpatient Progress note |  |  |
`http://loinc.org` | 100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note |  |  |
`http://loinc.org` | 100490-2 | Nurse practitioner Outpatient Progress note |  |  |
`http://loinc.org` | 100491-0 | Nurse Outpatient Progress note |  |  |
`http://loinc.org` | 100492-8 | Nutrition and dietetics Outpatient Progress note |  |  |
`http://loinc.org` | 100493-6 | Obstetrics and Gynecology Outpatient Progress note |  |  |
`http://loinc.org` | 100494-4 | Obstetrics Outpatient Progress note |  |  |
`http://loinc.org` | 10049-5 | S wave duration in lead I |  |  |
`http://loinc.org` | 100495-1 | Occupational therapy Outpatient Progress note |  |  |
`http://loinc.org` | 100496-9 | Oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100497-7 | Ophthalmology Outpatient Progress note |  |  |
`http://loinc.org` | 100498-5 | Optometry Outpatient Progress note |  |  |
`http://loinc.org` | 100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100500-8 | Orthopaedic surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100501-6 | Orthotics prosthetics Outpatient Progress note |  |  |
`http://loinc.org` | 100502-4 | Otolaryngology Outpatient Progress note |  |  |
`http://loinc.org` | 10050-3 | S wave duration in lead II |  |  |
`http://loinc.org` | 100503-2 | Pain medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100504-0 | Palliative care Outpatient Progress note |  |  |
`http://loinc.org` | 100505-7 | Pediatric cardiology Outpatient Progress note |  |  |
`http://loinc.org` | 100506-5 | Pediatric dermatology Outpatient Progress note |  |  |
`http://loinc.org` | 100507-3 | Pediatric endocrinology Outpatient Progress note |  |  |
`http://loinc.org` | 100508-1 | Pediatric gastroenterology Outpatient Progress note |  |  |
`http://loinc.org` | 100509-9 | Pediatric hematology-oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100510-7 | Pediatric infectious diseases Outpatient Progress note |  |  |
`http://loinc.org` | 10051-1 | S wave duration in lead III |  |  |
`http://loinc.org` | 100511-5 | Pediatric otolaryngology Outpatient Progress note |  |  |
`http://loinc.org` | 100512-3 | Pediatric pulmonology Outpatient Progress note |  |  |
`http://loinc.org` | 100513-1 | Pediatric rheumatology Outpatient Progress note |  |  |
`http://loinc.org` | 100514-9 | Pediatric surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100515-6 | Pediatric transplant hepatology Outpatient Progress note |  |  |
`http://loinc.org` | 100516-4 | Pediatric urology Outpatient Progress note |  |  |
`http://loinc.org` | 100517-2 | Pharmacogenomics Outpatient Progress note |  |  |
`http://loinc.org` | 100518-0 | Physical medicine and rehab Outpatient Progress note |  |  |
`http://loinc.org` | 100519-8 | Physical therapy Outpatient Progress note |  |  |
`http://loinc.org` | 100520-6 | Plastic surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100521-4 | Podiatry Outpatient Progress note |  |  |
`http://loinc.org` | 100522-2 | Psychiatry Hospital Progress note |  |  |
`http://loinc.org` | 100523-0 | Psychology Outpatient Progress note |  |  |
`http://loinc.org` | 100524-8 | Pulmonary Outpatient Progress note |  |  |
`http://loinc.org` | 100525-5 | Radiation oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100526-3 | Radiology Outpatient Progress note |  |  |
`http://loinc.org` | 100527-1 | Recreational therapy Outpatient Progress note |  |  |
`http://loinc.org` | 100528-9 | Reproductive endocrinology and infertility Outpatient Progress note |  |  |
`http://loinc.org` | 10052-9 | S wave duration in lead V1 |  |  |
`http://loinc.org` | 100529-7 | Research Outpatient Progress note |  |  |
`http://loinc.org` | 100530-5 | Rheumatology Outpatient Progress note |  |  |
`http://loinc.org` | 100531-3 | Sleep medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100532-1 | Social worker Outpatient Progress note |  |  |
`http://loinc.org` | 100533-9 | Solid Organ Transplant Outpatient Progress note |  |  |
`http://loinc.org` | 100534-7 | Speech-language pathology Outpatient Progress note |  |  |
`http://loinc.org` | 100535-4 | Spinal surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100536-2 | Sports medicine Outpatient Progress note |  |  |
`http://loinc.org` | 10053-7 | S wave duration in lead V2 |  |  |
`http://loinc.org` | 100537-0 | Surgery of the hand Outpatient Progress note |  |  |
`http://loinc.org` | 100538-8 | Telehealth+Outpatient Progress note |  |  |
`http://loinc.org` | 100539-6 | Thromboembolism Outpatient Progress note |  |  |
`http://loinc.org` | 100540-4 | Transplant surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100541-2 | Trauma Outpatient Progress note |  |  |
`http://loinc.org` | 100542-0 | Urology Outpatient Progress note |  |  |
`http://loinc.org` | 100543-8 | Vascular neurology Outpatient Progress note |  |  |
`http://loinc.org` | 100544-6 | Vascular surgery Outpatient Progress note |  |  |
`http://loinc.org` | 10054-5 | S wave duration in lead V3 |  |  |
`http://loinc.org` | 100545-3 | Wound care management Outpatient Progress note |  |  |
`http://loinc.org` | 100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note |  |  |
`http://loinc.org` | 100547-9 | Adolescent medicine Hospital Progress note |  |  |
`http://loinc.org` | 100548-7 | Allergy and Immunology Hospital Progress note |  |  |
`http://loinc.org` | 100549-5 | Allergy Hospital Progress note |  |  |
`http://loinc.org` | 100550-3 | Attending Hospital Progress note |  |  |
`http://loinc.org` | 100551-1 | Audiology Hospital Progress note |  |  |
`http://loinc.org` | 10055-2 | S wave duration in lead V4 |  |  |
`http://loinc.org` | 100552-9 | Bariatric surgery Hospital Progress note |  |  |
`http://loinc.org` | 100553-7 | Blood banking and transfusion medicine Hospital Progress note |  |  |
`http://loinc.org` | 100554-5 | Bone Marrow Transplant Hospital Progress note |  |  |
`http://loinc.org` | 100555-2 | Breastfeeding Hospital Progress note |  |  |
`http://loinc.org` | 100556-0 | Burn management Hospital Progress note |  |  |
`http://loinc.org` | 100557-8 | Cardiac surgery Hospital Progress note |  |  |
`http://loinc.org` | 100558-6 | Cardiopulmonary Hospital Progress note |  |  |
`http://loinc.org` | 100559-4 | Child and adolescent psychiatry Hospital Progress note |  |  |
`http://loinc.org` | 10056-0 | S wave duration in lead V5 |  |  |
`http://loinc.org` | 100560-2 | Clinical cardiac electrophysiology Hospital Progress note |  |  |
`http://loinc.org` | 100561-0 | Clinical genetics Hospital Progress note |  |  |
`http://loinc.org` | 100562-8 | Clinical neurophysiology Hospital Progress note |  |  |
`http://loinc.org` | 100563-6 | Clinical pathology Hospital Progress note |  |  |
`http://loinc.org` | 100564-4 | Colon and rectal surgery Hospital Progress note |  |  |
`http://loinc.org` | 100565-1 | Consultant Hospital Progress note |  |  |
`http://loinc.org` | 100566-9 | Dentistry Hospital Progress note |  |  |
`http://loinc.org` | 100567-7 | Dermatology Hospital Progress note |  |  |
`http://loinc.org` | 100568-5 | Developmental-behavioral pediatrics Hospital Progress note |  |  |
`http://loinc.org` | 100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note |  |  |
`http://loinc.org` | 100570-1 | Eating disorders Hospital Progress note |  |  |
`http://loinc.org` | 100571-9 | Endocrinology Hospital Progress note |  |  |
`http://loinc.org` | 100572-7 | Family medicine Hospital Progress note |  |  |
`http://loinc.org` | 100573-5 | Gastroenterology Hospital Progress note |  |  |
`http://loinc.org` | 100574-3 | General medicine Hospital Progress note |  |  |
`http://loinc.org` | 100575-0 | Geriatric medicine Hospital Progress note |  |  |
`http://loinc.org` | 100576-8 | Gynecologic oncology Hospital Progress note |  |  |
`http://loinc.org` | 100577-6 | Gynecology Hospital Progress note |  |  |
`http://loinc.org` | 10057-8 | S wave duration in lead V6 |  |  |
`http://loinc.org` | 100578-4 | Healthcare navigator Hospital Progress note |  |  |
`http://loinc.org` | 100579-2 | Heart failure Hospital Progress note |  |  |
`http://loinc.org` | 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100580-0 | Heart failure+Transplant cardiology Hospital Progress note |  |  |
`http://loinc.org` | 100581-8 | Hematology Hospital Progress note |  |  |
`http://loinc.org` | 100582-6 | Hematology+Medical oncology Hospital Progress note |  |  |
`http://loinc.org` | 100583-4 | Hepatology Hospital Progress note |  |  |
`http://loinc.org` | 100584-2 | Immunology Hospital Progress note |  |  |
`http://loinc.org` | 100585-9 | Infectious disease Hospital Progress note |  |  |
`http://loinc.org` | 10058-6 | S' wave amplitude in lead AVF |  |  |
`http://loinc.org` | 100586-7 | Internal medicine Hospital Progress note |  |  |
`http://loinc.org` | 100587-5 | Interventional cardiology Hospital Progress note |  |  |
`http://loinc.org` | 100588-3 | Interventional radiology Hospital Progress note |  |  |
`http://loinc.org` | 100589-1 | Hospital Mechanical circulatory support Progress note |  |  |
`http://loinc.org` | 100590-9 | Medical Aid in Dying Hospital Progress note |  |  |
`http://loinc.org` | 100591-7 | Mental health Hospital Progress note |  |  |
`http://loinc.org` | 100592-5 | Multi-specialty program Hospital Progress note |  |  |
`http://loinc.org` | 100593-3 | Neonatal perinatal medicine Hospital Progress note |  |  |
`http://loinc.org` | 10059-4 | S' wave amplitude in lead AVL |  |  |
`http://loinc.org` | 100594-1 | Nephrology Hospital Progress note |  |  |
`http://loinc.org` | 100595-8 | Neurological surgery Hospital Progress note |  |  |
`http://loinc.org` | 100596-6 | Neurology Hospital Progress note |  |  |
`http://loinc.org` | 100597-4 | Neurology with special qualifications in child neurology Hospital Progress note |  |  |
`http://loinc.org` | 100598-2 | Nurse practitioner Hospital Progress note |  |  |
`http://loinc.org` | 100599-0 | Nurse Hospital Progress note |  |  |
`http://loinc.org` | 100600-6 | Nutrition and dietetics Hospital Progress note |  |  |
`http://loinc.org` | 100601-4 | Obstetrics and Gynecology Hospital Progress note |  |  |
`http://loinc.org` | 10060-2 | S' wave amplitude in lead AVR |  |  |
`http://loinc.org` | 100602-2 | Obstetrics Hospital Progress note |  |  |
`http://loinc.org` | 100603-0 | Occupational therapy Hospital Progress note |  |  |
`http://loinc.org` | 100604-8 | Oncology Hospital Progress note |  |  |
`http://loinc.org` | 100605-5 | Ophthalmology Hospital Progress note |  |  |
`http://loinc.org` | 100606-3 | Oral and Maxillofacial Surgery Hospital Progress note |  |  |
`http://loinc.org` | 100607-1 | Orthopaedic surgery Hospital Progress note |  |  |
`http://loinc.org` | 100608-9 | Orthotics prosthetics Hospital Progress note |  |  |
`http://loinc.org` | 100609-7 | Otolaryngology Hospital Progress note |  |  |
`http://loinc.org` | 10061-0 | S' wave amplitude in lead I |  |  |
`http://loinc.org` | 100610-5 | Pain medicine Hospital Progress note |  |  |
`http://loinc.org` | 100611-3 | Palliative care Hospital Progress note |  |  |
`http://loinc.org` | 100612-1 | Pastoral care Hospital Progress note |  |  |
`http://loinc.org` | 100613-9 | Pediatric cardiology Hospital Progress note |  |  |
`http://loinc.org` | 100614-7 | Pediatric dermatology Hospital Progress note |  |  |
`http://loinc.org` | 100615-4 | Pediatric endocrinology Hospital Progress note |  |  |
`http://loinc.org` | 100616-2 | Pediatric gastroenterology Hospital Progress note |  |  |
`http://loinc.org` | 100617-0 | Pediatric hematology-oncology Hospital Progress note |  |  |
`http://loinc.org` | 100618-8 | Pediatric infectious diseases Hospital Progress note |  |  |
`http://loinc.org` | 100619-6 | Pediatric otolaryngology Hospital Progress note |  |  |
`http://loinc.org` | 100620-4 | Pediatric pulmonology Hospital Progress note |  |  |
`http://loinc.org` | 100621-2 | Pediatric rheumatology Hospital Progress note |  |  |
`http://loinc.org` | 100622-0 | Pediatric surgery Hospital Progress note |  |  |
`http://loinc.org` | 100623-8 | Pediatric transplant hepatology Hospital Progress note |  |  |
`http://loinc.org` | 100624-6 | Pharmacogenomics Hospital Progress note |  |  |
`http://loinc.org` | 100625-3 | Pharmacology Hospital Progress note |  |  |
`http://loinc.org` | 100626-1 | Physical medicine and rehab Hospital Progress note |  |  |
`http://loinc.org` | 100627-9 | Physical therapy Hospital Progress note |  |  |
`http://loinc.org` | 10062-8 | S' wave amplitude in lead II |  |  |
`http://loinc.org` | 100628-7 | Plastic surgery Hospital Progress note |  |  |
`http://loinc.org` | 100629-5 | Podiatry Hospital Progress note |  |  |
`http://loinc.org` | 100630-3 | Psychology Hospital Progress note |  |  |
`http://loinc.org` | 100631-1 | Radiation oncology Hospital Progress note |  |  |
`http://loinc.org` | 100632-9 | Radiology Hospital Progress note |  |  |
`http://loinc.org` | 100633-7 | Rapid response team Hospital Progress note |  |  |
`http://loinc.org` | 100634-5 | Recreational therapy Hospital Progress note |  |  |
`http://loinc.org` | 100635-2 | Reproductive endocrinology and infertility Hospital Progress note |  |  |
`http://loinc.org` | 10063-6 | S' wave amplitude in lead III |  |  |
`http://loinc.org` | 100636-0 | Research Hospital Progress note |  |  |
`http://loinc.org` | 100637-8 | Rheumatology Hospital Progress note |  |  |
`http://loinc.org` | 100638-6 | Sleep medicine Hospital Progress note |  |  |
`http://loinc.org` | 100639-4 | Social worker Hospital Progress note |  |  |
`http://loinc.org` | 100640-2 | Solid Organ Transplant Hospital Progress note |  |  |
`http://loinc.org` | 100641-0 | Speech-language pathology Hospital Progress note |  |  |
`http://loinc.org` | 100642-8 | Spinal surgery Hospital Progress note |  |  |
`http://loinc.org` | 100643-6 | Surgery of the hand Hospital Progress note |  |  |
`http://loinc.org` | 10064-4 | S' wave amplitude in lead V1 |  |  |
`http://loinc.org` | 100644-4 | Thromboembolism Hospital Progress note |  |  |
`http://loinc.org` | 100645-1 | Trauma Hospital Progress note |  |  |
`http://loinc.org` | 100646-9 | Urology Hospital Progress note |  |  |
`http://loinc.org` | 100647-7 | Vascular neurology Hospital Progress note |  |  |
`http://loinc.org` | 100648-5 | Vascular surgery Hospital Progress note |  |  |
`http://loinc.org` | 100649-3 | Wound care management Hospital Progress note |  |  |
`http://loinc.org` | 100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note |  |  |
`http://loinc.org` | 10065-1 | S' wave amplitude in lead V2 |  |  |
`http://loinc.org` | 100651-9 | Hospital COVID-19 Intubation Progress note |  |  |
`http://loinc.org` | 100652-7 | Pure tone bone conduction threshold audiometry panel |  |  |
`http://loinc.org` | 100653-5 | Deprecated Pure tone air conduction threshold audiometry panel | DEPRECATED |  |
`http://loinc.org` | 100654-3 | Pyruvate kinase M2 [Presence] in Stool |  |  |
`http://loinc.org` | 100655-0 | XR Sella turcica Lateral |  |  |
`http://loinc.org` | 100656-8 | Maternal and fetal medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note |  |  |
`http://loinc.org` | 100658-4 | Hospital COVID-19 Progress note |  |  |
`http://loinc.org` | 100659-2 | Maternal and fetal medicine Hospital Progress note |  |  |
`http://loinc.org` | 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |  |  |
`http://loinc.org` | 100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |  |  |
`http://loinc.org` | 100661-8 | Psychiatry Outpatient Progress note |  |  |
`http://loinc.org` | 100662-6 | Cortisol free and total panel - Serum or Plasma |  |  |
`http://loinc.org` | 100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 10066-9 | S' wave amplitude in lead V3 |  |  |
`http://loinc.org` | 100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |  |  |
`http://loinc.org` | 100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 10067-7 | S' wave amplitude in lead V4 |  |  |
`http://loinc.org` | 100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 10068-5 | S' wave amplitude in lead V5 |  |  |
`http://loinc.org` | 100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |  |  |
`http://loinc.org` | 100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |  |  |
`http://loinc.org` | 100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |  |  |
`http://loinc.org` | 100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |  |  |
`http://loinc.org` | 10069-3 | S' wave amplitude in lead V6 |  |  |
`http://loinc.org` | 100693-1 | Pneumocystis jirovecii DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |  |  |
`http://loinc.org` | 100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100697-2 | Interventional radiology Outpatient Note |  |  |
`http://loinc.org` | 100698-0 | Social Determinants of Health screening report Document |  |  |
`http://loinc.org` | 100699-8 | Rifabutin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |  |  |
`http://loinc.org` | 10070-1 | S' wave duration in lead AVF |  |  |
`http://loinc.org` | 100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |  |  |
`http://loinc.org` | 100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |  |  |
`http://loinc.org` | 100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |  |  |
`http://loinc.org` | 100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |  |  |
`http://loinc.org` | 100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |  |  |
`http://loinc.org` | 100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100707-9 | Granulocytes [#/volume] in Peritoneal dialysis fluid by Automated count |  |  |
`http://loinc.org` | 100708-7 | Plasma cells/Leukocytes in Synovial fluid |  |  |
`http://loinc.org` | 100709-5 | Hepatocellular carcinoma risk [Score] by GAAD |  |  |
`http://loinc.org` | 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |  |  |
`http://loinc.org` | 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100713-7 | Cariprazine [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100714-5 | Guanfacine [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100716-0 | Prostate specific Ag [Mass/volume] in DBS |  |  |
`http://loinc.org` | 100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 100718-6 | Undersea and hyperbaric medicine Discharge summary |  |  |
`http://loinc.org` | 10071-9 | S' wave duration in lead AVL |  |  |
`http://loinc.org` | 100719-4 | Surgical oncology Discharge summary |  |  |
`http://loinc.org` | 100720-2 | Reproductive endocrinology and infertility Discharge summary |  |  |
`http://loinc.org` | 100721-0 | Community health care Discharge summary |  |  |
`http://loinc.org` | 100722-8 | Integrative medicine Discharge summary |  |  |
`http://loinc.org` | 100723-6 | Sports medicine Discharge summary |  |  |
`http://loinc.org` | 100724-4 | Diabetology Discharge summary |  |  |
`http://loinc.org` | 100725-1 | Optometry Discharge summary |  |  |
`http://loinc.org` | 100726-9 | Podiatry Discharge summary |  |  |
`http://loinc.org` | 10072-7 | S' wave duration in lead AVR |  |  |
`http://loinc.org` | 100727-7 | Chiropractic medicine Discharge summary |  |  |
`http://loinc.org` | 100728-5 | Cardiac surgery Discharge summary |  |  |
`http://loinc.org` | 100729-3 | Breastfeeding Discharge summary |  |  |
`http://loinc.org` | 100730-1 | Transplant surgery Discharge summary |  |  |
`http://loinc.org` | 100731-9 | Urgent care center Discharge summary |  |  |
`http://loinc.org` | 100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |  |  |
`http://loinc.org` | 100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |  |  |
`http://loinc.org` | 100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method |  |  |
`http://loinc.org` | 10073-5 | S' wave duration in lead I |  |  |
`http://loinc.org` | 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |  |  |
`http://loinc.org` | 100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document |  |  |
`http://loinc.org` | 100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |  |  |
`http://loinc.org` | 100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 10074-3 | S' wave duration in lead II |  |  |
`http://loinc.org` | 100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |  |  |
`http://loinc.org` | 100745-9 | Chloride [Moles/volume] in Mixed venous blood |  |  |
`http://loinc.org` | 100746-7 | Glucose [Moles/volume] in Mixed venous blood |  |  |
`http://loinc.org` | 100747-5 | Legionella serogroup panel - Specimen |  |  |
`http://loinc.org` | 100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 10075-0 | S' wave duration in lead III |  |  |
`http://loinc.org` | 100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |  |  |
`http://loinc.org` | 100752-5 | Exacerbating factors - Reported |  |  |
`http://loinc.org` | 100753-3 | Alleviating factors - Reported |  |  |
`http://loinc.org` | 100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |  |  |
`http://loinc.org` | 100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |  |  |
`http://loinc.org` | 100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |  |  |
`http://loinc.org` | 100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |  |  |
`http://loinc.org` | 100758-2 | Estimated lung age by based on clinical data |  |  |
`http://loinc.org` | 100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry |  |  |
`http://loinc.org` | 100760-8 | XR Radius and Ulna - left Single view |  |  |
`http://loinc.org` | 100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative |  |  |
`http://loinc.org` | 100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |  |  |
`http://loinc.org` | 100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS |  |  |
`http://loinc.org` | 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] |  |  |
`http://loinc.org` | 100767-3 | Bothered by things that are not usually bothersome |  |  |
`http://loinc.org` | 10076-8 | S' wave duration in lead V1 |  |  |
`http://loinc.org` | 100768-1 | Poor appetite |  |  |
`http://loinc.org` | 100769-9 | Unhappy even with help from my family or friends |  |  |
`http://loinc.org` | 100770-7 | Feeling just as good as others |  |  |
`http://loinc.org` | 100771-5 | Trouble focusing |  |  |
`http://loinc.org` | 100772-3 | Feeling depressed |  |  |
`http://loinc.org` | 100773-1 | Feeling everything is too much of an effort |  |  |
`http://loinc.org` | 100774-9 | Feeling hopeful about the future |  |  |
`http://loinc.org` | 100775-6 | Feeling life had been a failure |  |  |
`http://loinc.org` | 10077-6 | S' wave duration in lead V2 |  |  |
`http://loinc.org` | 100776-4 | Feeling fearful |  |  |
`http://loinc.org` | 100777-2 | Restless sleep |  |  |
`http://loinc.org` | 100778-0 | Feeling happy |  |  |
`http://loinc.org` | 100779-8 | Quieter than usual |  |  |
`http://loinc.org` | 100780-6 | Feeling lonely |  |  |
`http://loinc.org` | 100781-4 | People were unfriendly |  |  |
`http://loinc.org` | 100782-2 | Enjoying life |  |  |
`http://loinc.org` | 100783-0 | Crying spells |  |  |
`http://loinc.org` | 10078-4 | S' wave duration in lead V3 |  |  |
`http://loinc.org` | 100784-8 | Feeling sad |  |  |
`http://loinc.org` | 100785-5 | Feeling people dislike me |  |  |
`http://loinc.org` | 100786-3 | Lack of energy |  |  |
`http://loinc.org` | 100787-1 | Total Score CES-D |  |  |
`http://loinc.org` | 100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 10079-2 | S' wave duration in lead V4 |  |  |
`http://loinc.org` | 100792-1 | Forsythia IgE Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100793-9 | Testosterone [Mass/volume] in Body fluid |  |  |
`http://loinc.org` | 100794-7 | Follitropin [Units/volume] in Body fluid |  |  |
`http://loinc.org` | 100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid |  |  |
`http://loinc.org` | 100796-2 | Thyroglobulin [Mass/volume] in Body fluid |  |  |
`http://loinc.org` | 100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |  |  |
`http://loinc.org` | 10080-0 | S' wave duration in lead V5 |  |  |
`http://loinc.org` | 100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |  |  |
`http://loinc.org` | 100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |  |  |
`http://loinc.org` | 100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |  |  |
`http://loinc.org` | 100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |  |  |
`http://loinc.org` | 100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |  |  |
`http://loinc.org` | 100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |  |  |
`http://loinc.org` | 100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |  |  |
`http://loinc.org` | 100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |  |  |
`http://loinc.org` | 100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |  |  |
`http://loinc.org` | 100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |  |  |
`http://loinc.org` | 100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |  |  |
`http://loinc.org` | 10081-8 | S' wave duration in lead V6 |  |  |
`http://loinc.org` | 100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100821-8 | National POLST form: portable medical order panel |  |  |
`http://loinc.org` | 100822-6 | Cardiopulmonary resuscitation orders |  |  |
`http://loinc.org` | 100823-4 | Initial portable medical treatment orders |  |  |
`http://loinc.org` | 100824-2 | Additional portable medical orders or instructions |  |  |
`http://loinc.org` | 100825-9 | Medically assisted nutrition orders |  |  |
`http://loinc.org` | 10082-6 | ST initial amplitude 6 ms in lead AVF |  |  |
`http://loinc.org` | 100826-7 | Portable medical order AndOr advance directive review |  |  |
`http://loinc.org` | 100827-5 | Portable medical order discussion participants |  |  |
`http://loinc.org` | 100828-3 | Portable medical order administrative information |  |  |
`http://loinc.org` | 100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 10083-4 | ST initial amplitude 6 ms in lead AVL |  |  |
`http://loinc.org` | 100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |  |  |
`http://loinc.org` | 100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |  |  |
`http://loinc.org` | 100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |  |  |
`http://loinc.org` | 100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |  |  |
`http://loinc.org` | 100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |  |  |
`http://loinc.org` | 100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |  |  |
`http://loinc.org` | 100840-8 | IgE [Units/volume] in Body fluid |  |  |
`http://loinc.org` | 100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |  |  |
`http://loinc.org` | 10084-2 | ST initial amplitude 6 ms in lead AVR |  |  |
`http://loinc.org` | 100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |  |  |
`http://loinc.org` | 100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |  |  |
`http://loinc.org` | 100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |  |  |
`http://loinc.org` | 100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |  |  |
`http://loinc.org` | 100847-3 | Gas and ammonia panel - Arterial blood |  |  |
`http://loinc.org` | 100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100852-3 | NM Bones Views for metastasis W Sr-89 IV |  |  |
`http://loinc.org` | 100853-1 | NM Pericardial space Views for effusion |  |  |
`http://loinc.org` | 100854-9 | Lymphocytes/cells in Blood mononuclear cells by Immunoassay | TRIAL |  |
`http://loinc.org` | 100855-6 | CD3 cells/cells in Blood mononuclear cells | TRIAL |  |
`http://loinc.org` | 100856-4 | CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells | TRIAL |  |
`http://loinc.org` | 100857-2 | CD3+CD8+ (T8 suppressor) cells/cells in Blood mononuclear cells | TRIAL |  |
`http://loinc.org` | 100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |  |
`http://loinc.org` | 10085-9 | ST initial amplitude 6 ms in lead I |  |  |
`http://loinc.org` | 100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |  |
`http://loinc.org` | 100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |  |
`http://loinc.org` | 100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |  |
`http://loinc.org` | 100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |  |
`http://loinc.org` | 100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |  |
`http://loinc.org` | 100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100866-3 | Febrile antibody profile in Serum |  |  |
`http://loinc.org` | 10086-7 | ST initial amplitude 6 ms in lead II |  |  |
`http://loinc.org` | 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |  |  |
`http://loinc.org` | 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |  |  |
`http://loinc.org` | 100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100874-7 | Basidiobolus sp [Presence] in Specimen |  |  |
`http://loinc.org` | 10087-5 | ST initial amplitude 6 ms in lead III |  |  |
`http://loinc.org` | 100875-4 | Fetal Heart Document limited US |  |  |
`http://loinc.org` | 100876-2 | Fetal Heart Document US |  |  |
`http://loinc.org` | 100877-0 | US Heart Transesophageal during surgery |  |  |
`http://loinc.org` | 100878-8 | Endoscopic ultrasound study Upper GI tract Document |  |  |
`http://loinc.org` | 100879-6 | US Guidance for cryoablation of Breast - right |  |  |
`http://loinc.org` | 100880-4 | US Guidance for cryoablation of Breast - left |  |  |
`http://loinc.org` | 100881-2 | MR Guidance for cryoablation of Bone |  |  |
`http://loinc.org` | 100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal |  |  |
`http://loinc.org` | 10088-3 | ST initial amplitude 6 ms in lead V1 |  |  |
`http://loinc.org` | 100883-8 | MR Guidance for biopsy of Kidney - left |  |  |
`http://loinc.org` | 100884-6 | MR Guidance for biopsy of Kidney - right |  |  |
`http://loinc.org` | 100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100888-7 | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100889-5 | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100890-3 | Poxvirus DNA panel |  |  |
`http://loinc.org` | 10089-1 | ST initial amplitude 6 ms in lead V2 |  |  |
`http://loinc.org` | 100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |  |  |
`http://loinc.org` | 100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |  |  |
`http://loinc.org` | 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |  |  |
`http://loinc.org` | 100894-5 | Recommended screening frequency Narrative |  |  |
`http://loinc.org` | 100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum |  |  |
`http://loinc.org` | 100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |  |  |
`http://loinc.org` | 100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |  |  |
`http://loinc.org` | 100898-6 | Lipid panel - Serum or Plasma |  |  |
`http://loinc.org` | 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |  |  |

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code